| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 710549 | Null | 0.0430505868034764 | -0.043190166 |
| NSC 710716 | Null | 0.0430505868034764 | 0.41264815 |
| NSC 716032 | Null | 0.0430505868034764 | 0.19004196 |
| NSC 716951 | Null | 0.0430505868034764 | 0.23036691 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0430505868034764 | 0.24590484 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0430505868034764 | 0.20671091 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0430505868034764 | 0.28059767 |
| NSC 735373 | Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) | 0.0430505868034764 | 0.16064705 |
| NSC 736041 | 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne | 0.0430505868034764 | 0.2655161 |
| NSC 740 | Methotrexate | 0.0430505868034764 | 0.19045288 |